Search Within

Christopher G Azzoli

  1. "Daniel Milton"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (4)
  2. Nursing (4)
  3. Solid Tumor Oncology Division (4)
  4. Thoracic Oncology (4)
  5. Advanced Practice Providers (2)
  6. Survivorship Research (2)

More Groups

People
  1. Daniel Milton (4)
  2. Jorge Gomez (4)
  3. Lee Krug (4)
  4. Mark Kris (4)
  5. Naiyer Rizvi (4)
  6. Robert Heelan (4)

More People

Years
  1. 2007 (1)
  2. 2006 (1)
  3. 2005 (1)
  4. 2004 (1)
Publications
  1. Cancer (2)
  2. Journal of Clinical Oncology (2)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Wiley Blackwell (2)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer
    Journal Article

    Milton, D. T.; Riely, G. J.; Azzoli, C. G.; Gomez, J. E.; Heelan, R. T.; Kris, M. G.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; more...
    Cancer (2007)

    Fulltext@MSK | Save
  • A Phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
    Journal Article

    Milton, D. T.; Azzoli, C. G.; Heelan, R. T.; Venkatraman, E.; Gomez, J. E.; Kris, M. G.; Krug, L. M.; Pao, W.; Rizvi, N. A.; Dunne, M.; more...
    Cancer (2006)

    Fulltext@MSK | Save
  • Phase I/II trial of gefitinib and RAD001 (everolimus) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Milton, D. T.; Kris, M. G.; Azzoli, C. G.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; Miller, V. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Weekly high-dose erlotinib in patients with non-small cell lung cancer (NSCLC): A phase I/II study
    Meeting Abstract

    Milton, D. T.; Miller, V. A.; Azzoli, C. G.; Dunne, M.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Ramies, D.; Rizvi, N. A.; Kris, M. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save